U.S. cardiovascular company IPO financing volume 2006-2022
Illustrated is the amount of money which emerging therapeutic companies in the U.S. cardiovascular disease and disorders segment raised through initial public offerings from 2006 to 2022. During 2022, such companies in the U.S. raised 194 million dollars by going public.